1. Home
  2. ETS vs ADXN Comparison

ETS vs ADXN Comparison

Compare ETS & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$0.53

Market Cap

8.9M

Sector

Industrials

ML Signal

N/A

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

HOLD

Current Price

$7.94

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETS
ADXN
Founded
2020
2002
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
10.3M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ETS
ADXN
Price
$0.53
$7.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
70.9K
3.2K
Earning Date
02-03-2026
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,585,885.00
$198,824.00
Revenue This Year
N/A
$86.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.59
N/A
52 Week Low
$0.49
$6.51
52 Week High
$4.23
$12.05

Technical Indicators

Market Signals
Indicator
ETS
ADXN
Relative Strength Index (RSI) N/A 45.86
Support Level N/A $7.72
Resistance Level N/A $8.90
Average True Range (ATR) 0.00 0.40
MACD 0.00 0.02
Stochastic Oscillator 0.00 16.08

Price Performance

Historical Comparison
ETS
ADXN

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: